Last month, the Food and Drug Administration (FDA) approved Voquenza Dual (vonoprazan fumarate + amoxicillin) and Triple Paks (vonoprazan fumarate + amoxicillin + clarithromycin) for the treatment of ...

Helicobacter pylori is a Gram-negative bacterium commonly found in the gastric epithelium. Infection of the gastrointestinal tract by Helicobacter pylori results in gastritis, peptic ulcer, and ...

New insights into how the cancer-causing stomach bacterium keeps its shape could point the way for future, more-specialized antibiotics One of H. pylori’s defining characteristics is right there in ...

A recent investigation reveals that Helicobacter pylori was present in nearly 39% of gastritis cases, demonstrating a ...

In 1982, two Australians – Robin Warren and Barry Marshall – presented their first observations of strange bacteria living in the human stomach. They went on to propose that these bacteria caused a ...

H pylori infection should be confirmed before eradication therapy. Accurate, cost-effective tests to diagnose the infection are now commercially available. Tests that do not require endoscopy include ...

Helicobacter pylori in the human stomach, taken by a scanning electron microscope. Copyright Martin Blaser 1989 A few weeks ago, researchers announced that a 5,300 ...

Helicobacter pylori infection is a chronic gastric Gram-negative infection that increases with age worldwide. The prevalence of H. pylori detection appears to decrease in frail patients aged over 85 ...

The American Journal of Managed Care® (AJMC®): What has led to the recent increase in attention given to Helicobacter pylori treatments? Our group, as well as other groups in the United States, [has] ...

A breakthrough in identifying how a common ulcer-causing bacteria survives in the human stomach will lead to new medications and possible eradication, according to a WA Nobel Prize-winning scientist.